Bile composition in Alagille Syndrome and PFIC patients having Partial External Biliary Diversion

被引:19
作者
Emerick, Karan M. [1 ,2 ]
Elias, Marc S. [2 ]
Melin-Aldana, Hector [1 ,2 ]
Strautnieks, Sandra [3 ]
Thompson, Richard J. [3 ]
Bull, Laura N. [4 ]
Knisely, A. S. [5 ]
Whitington, Peter F. [1 ,2 ]
Green, Richard M. [2 ]
机构
[1] Childrens Mem Hosp, Chicago, IL 60614 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Kings Coll London, Sch Med, Dept Liver Studies & Transplantat, London WC2R 2LS, England
[4] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA
[5] Kings Coll London, Inst Liver Studies, London WC2R 2LS, England
关键词
D O I
10.1186/1471-230X-8-47
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Partial External Biliary Diversion (PEBD) is a surgical intervention to treat children with Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille syndrome (AGS). PEBD can reduce disease progression, and examining the alterations in biliary lipid composition may be a prognostic factor for outcome. Methods: Biliary lipid composition and the clinical course of AGS and PFIC patients were examined before and after PEBD. Results: Pre-PEBD bile from AGS patients had greater chenodeoxycholic/cholic acid (CDCA/CA), bile salt, cholesterol and phospholipid concentrations than PFIC patients. AGS patients, and PFIC patients with familial intrahepatic cholestasis 1 (FIC1) genotype, responded better to PEBD than PFIC patients with bile salt export protein (BSEP) genotype. After successful PEBD, AGS patients have higher biliary lipid concentrations than PFIC patients and PEBD also increases biliary phospholipid concentrations in FIC1 patients. Conclusion: Both AGS and FIC1 patients can benefit from PEBD, and preserved biliary phospholipid concentrations may be associated with better outcomes post-PEBD.
引用
收藏
页数:10
相关论文
共 37 条
[1]
SYNDROMIC PAUCITY OF INTERLOBULAR BILE-DUCTS (ALAGILLE SYNDROME OR ARTERIOHEPATIC DYSPLASIA) - REVIEW OF 80 CASES [J].
ALAGILLE, D ;
ESTRADA, A ;
HADCHOUEL, M ;
GAUTIER, M ;
ODIEVRE, M ;
DOMMERGUES, JP .
JOURNAL OF PEDIATRICS, 1987, 110 (02) :195-200
[2]
HISTOLOGIC PATHOLOGY OF THE LIVER IN PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS [J].
ALONSO, EM ;
SNOVER, DC ;
MONTAG, A ;
FREESE, DK ;
WHITINGTON, PF .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1994, 18 (02) :128-133
[3]
BARTLETT GR, 1959, J LIPID RES, V30, P719
[4]
PARAMETERS OF LIPOPROTEIN METABOLISM AND CHOLESTASIS IN HEALTHY AND CHOLESTATIC INFANTS AND CHILDREN [J].
BOJANOVSKI, M ;
LUKERMANN, R ;
SCHULZFALTEN, J ;
STURM, E ;
BURDELSKI, M ;
BOJANOVSKI, D .
PROGRESS IN LIPID RESEARCH, 1991, 30 (2-3) :295-300
[5]
Bull LN, 1997, HEPATOLOGY, V26, P155
[6]
A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis [J].
Bull, LN ;
van Eijk, MJT ;
Pawlikowska, L ;
DeYoung, JA ;
Juijn, JA ;
Liao, M ;
Klomp, LWJ ;
Lomri, N ;
Berger, R ;
Scharschmidt, BF ;
Knisely, AS ;
Houwen, RHJ ;
Freimer, NB .
NATURE GENETICS, 1998, 18 (03) :219-224
[7]
Molecular basis of intrahepatic cholestasis [J].
Carlton, VEH ;
Pawlikowska, L ;
Bull, LN .
ANNALS OF MEDICINE, 2004, 36 (08) :606-617
[8]
Abnormal lipoprotein pattern in patients with Alagille syndrome depends on icterus severity [J].
DavitSpraul, A ;
Pourci, ML ;
Atger, V ;
Cambillau, M ;
Hadchouel, M ;
Moatti, N ;
Legrand, A .
GASTROENTEROLOGY, 1996, 111 (04) :1023-1032
[9]
Clinical aspects of familial cholestasis (with molecular explanations). [J].
Emerick K.M. ;
Whitington P.F. .
Current Gastroenterology Reports, 1999, 1 (3) :223-230
[10]
Partial external biliary diversion for intractable pruritus and xanthomas in Alagille syndrome [J].
Emerick, KM ;
Whitington, PF .
HEPATOLOGY, 2002, 35 (06) :1501-1506